Company intelligence / Profile preview

Beacon Capital Partners

Boston, Massachusetts, United Statesbeaconcapital.com ↗

Ownership: Private
Development stage: Other

Overview

Beacon Capital Partners is one of the largest private real estate investment firms specializing in office and life science properties across major U.S. markets. Through its “Beacon Pharma” initiative, it also operates an incubator and seed fund providing funding ($30k–$1M per startup), lab space, and manufacturing facilities to early-stage biotech companies focused on oncology, neurodegenerative disorders, and rare diseases. The firm does not develop drugs itself but plays a critical enabling role for biotech innovation by providing infrastructure and capital support.

Therapeutic areas: OncologyRare DiseasesNeurology
Modalities: Small moleculeBiologicGene therapy
Industry: Investors

Partnerships

MassBio – partnership to launch workforce training center for life sciences industry at Southline Boston redevelopment project

Beyond the preview

Go deeper on Beacon Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beacon Capital Partners.

Explore the full profile